News

Advanced Life Sciences has reported positive top-line results from a pivotal, non-human primate study of its once-a-day, oral antibiotic Restanza (cethromycin) against an inhaled lethal dose of Tularemia.

Cellular Dynamics International (CDI) has launched iCell Cardiomyocytes for use in testing of new drug candidates by the pharmaceutical industry. These human heart cells are designed to aid

GlaxoSmithKline (GSK) and NanoBio has entered into an exclusive licensing agreement in the US and Canada for the over-the-counter (OTC) use of NB-001, a patented compound representing the

Onset Therapeutics (Onset) has reported positive results from a skin moisturisation study that compared the company’s recently launched BenzEFoam (benzoyl peroxide 5.3%) emollient foam to combination gel containing

As part of its effort to enter the fast-growing and high-potential Scar Management segment, Glenmark has in-licensed its first product for the Indian market. The company entered into

Merck KGaA (Merck) has inaugurated the expansion of its Advanced Technologies Centre at Chilworth near Southampton, the UK. For around ten years, the Chilworth site has served as

OSI Pharmaceuticals and Genentech, a wholly owned member of the Roche Group have reported that the FDA Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against

Ipca Laboratories has received approval for its anti-malarial finished fixed dose combination formulation of ‘Artemether + Lumefantrine’, under WHO’s Pre-qualification Programme. The product is now listed in the

WaferGen is going to launch the human MicroRNA panel for its service for gene-expression profiling using its SmartChip real-time PCR system. The human MicroRNA panel provides a comprehensive